Therapeutic potential of spleen tyrosine kinase inhibition for treatment of high-risk precursor B-cell acute lymphoblastic leukemia - refine.bio

GSE56345

Mus musculus

9 Downloadable Samples

Technology Badge Icon

Affymetrix Mouse Genome 430 2.0 Array (mouse4302)

Submitter Supplied Information

Description

This study revealed pathogenic role of pre-BCR-independent SYK activation in high-risk B-ALL.

PubMed ID

Publication Title

Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.

Total Samples

9

Submitter’s Institution

The Hospital for Sick Children

Authors

Perova T, Grandal I, Nutter LM, Papp E, Matei IR, Beyene J, Kowalski PE, Hitzler JK, Minden MD, Guidos CJ, Danska JS

Source Repository

Gene Expression Omnibus (GEO)

No rows found

Loading...